OHSU scientists have developed a comprehensive, open-access database mapping lipid-protein interactions — a foundational research resource designed to unlock lipids' potential in treating and preventing disease. While lipids are known to play critical roles in inflammation, cancer, cardiovascular disease, and neurodegeneration, the field has lacked the kind of organized, queryable interaction data that genomics and proteomics have enjoyed for years. OHSU's database changes that.

The research significance lies in the database's ability to connect lipid biology to actionable drug targets. Pharmaceutical development has historically underexploited lipid pathways, partly because the interaction data was scattered across thousands of individual papers rather than consolidated in a searchable format. By systematizing these interactions, OHSU researchers are effectively creating a roadmap for lipid-based therapeutic discovery — one that could yield new approaches to conditions ranging from atherosclerosis to Alzheimer's disease.

For Oregon's healthcare and research ecosystem, the database represents institutional infrastructure that attracts collaboration and funding. OHSU investigators across departments — from the Knight Cancer Institute to the neuroscience program — can use it to generate preliminary data for grant applications. Biotech startups in Portland's growing life sciences sector may find commercial applications. Clinically, while the database's impact is upstream of patient care today, it contributes to the long-term precision medicine vision in which a patient's lipid metabolism profile informs individualized treatment decisions.

Watch for NIH-funded studies citing the database and whether Oregon biotech companies leverage it for therapeutic development pipelines.